Sakari Knuutila
YOU?
Author Swipe
View article: Correction: Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts
Correction: Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts Open
View article: Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts
Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts Open
View article: The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients
The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients Open
Background: Stools from colorectal cancer patients are noninvasive samples that could be used to compare the frequency of hotspot mutations between two different ethnic cohorts. Materials and Methods: We collected stool samples from the Ir…
View article: Supplementary Figure 4 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 4 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 62KB, Kaplan-Meier PFS according to level of expression of hsa-miR-31-3p in the whole series of 132 patients. For the 102 patients who were NRAS wild-type based on Sanger sequencing of exon 2 and 3, the hazard ratio was 2.51 CI9…
View article: Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors Open
Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
View article: Supplementary Figure 5 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 5 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 64KB, Regression analysis of the log transformed hsa-miR-31-3p and gene expression levels plotted on x-axis and y-axis, respectively. The name of the gene and correlation p-values between expression values are indicated in the m…
View article: Supplementary Figure 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 60KB, The red spot indicates the area under the curve superior to 0.7 for predicting the PFS at different endpoints, blue spot indicates the area under the curve superior to 0.64 which corresponds to the mean of the area under t…
View article: Supplementary Figure 5 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 5 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 64KB, Regression analysis of the log transformed hsa-miR-31-3p and gene expression levels plotted on x-axis and y-axis, respectively. The name of the gene and correlation p-values between expression values are indicated in the m…
View article: Supplementary Materials and Methods, Figure Legends, Tables 1 - 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Materials and Methods, Figure Legends, Tables 1 - 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - KB, Supplementary Table S1. Taqman information for expression analysis of microRNAs. Supplementary Table S2. List of the 11 microRNAs used in the classifier model. Supplementary Table S3. List of the genes with a fc<0.77 (Down-r…
View article: Supplementary Figure 2 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 2 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 64KB, Kaplan-Meier PFS according to level of expression of hsa-miR-31-3p in training set 1.
View article: Data from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Data from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
Purpose: To identify microRNAs (miRNA) that predict response to anti-EGFR antibodies in patients with wild-type KRAS metastatic colorectal cancer (mCRC).Experimental Design: miRNA profiling was performed in a training …
View article: Supplementary Figure 4 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 4 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 62KB, Kaplan-Meier PFS according to level of expression of hsa-miR-31-3p in the whole series of 132 patients. For the 102 patients who were NRAS wild-type based on Sanger sequencing of exon 2 and 3, the hazard ratio was 2.51 CI9…
View article: Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors Open
Purpose: Histologic grade is currently the best predictor of clinical course in chondrosarcoma patients. Grading suffers, however, from extensive interobserver variability and new objective markers are needed. Hence, we have investi…
View article: Supplementary Figure 2 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 2 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 64KB, Kaplan-Meier PFS according to level of expression of hsa-miR-31-3p in training set 1.
View article: Data from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Data from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
Purpose: To identify microRNAs (miRNA) that predict response to anti-EGFR antibodies in patients with wild-type KRAS metastatic colorectal cancer (mCRC).Experimental Design: miRNA profiling was performed in a training …
View article: Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors Open
Purpose: Histologic grade is currently the best predictor of clinical course in chondrosarcoma patients. Grading suffers, however, from extensive interobserver variability and new objective markers are needed. Hence, we have investi…
View article: Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors Open
Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
View article: Supplementary Figure 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 60KB, The red spot indicates the area under the curve superior to 0.7 for predicting the PFS at different endpoints, blue spot indicates the area under the curve superior to 0.64 which corresponds to the mean of the area under t…
View article: Supplementary Figure 1 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 1 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 62KB, Kaplan-Meier curve for PFS according to the classification in high risk and low risk patients by the level of expression of 11 microRNAs.
View article: Supplementary Figure 1 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Figure 1 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - 62KB, Kaplan-Meier curve for PFS according to the classification in high risk and low risk patients by the level of expression of 11 microRNAs.
View article: Supplementary Materials and Methods, Figure Legends, Tables 1 - 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
Supplementary Materials and Methods, Figure Legends, Tables 1 - 3 from Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Open
PDF file - KB, Supplementary Table S1. Taqman information for expression analysis of microRNAs. Supplementary Table S2. List of the 11 microRNAs used in the classifier model. Supplementary Table S3. List of the genes with a fc<0.77 (Down-r…
View article: Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
View article: Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
View article: Supplementary Table 5 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Supplementary Table 5 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category Open
Supplementary Table 5 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
View article: Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
View article: Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Figure 1 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
View article: Data from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Data from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Asbestos is a well-known lung cancer-causing mineral fiber. In vitro and in vivo experiments have shown that asbestos can cause chromosomal damage and aberrations. Lung tumors, in general, have several recurrently amplified a…
View article: Supplementary Table 4 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Supplementary Table 4 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category Open
Supplementary Table 4 from Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
View article: Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Data and Figure Legends from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
View article: Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer
Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer Open
Supplementary Figure 2 from Identification of Specific Gene Copy Number Changes in Asbestos-Related Lung Cancer